Teva Parenteral Medicines Initiates Voluntary Nationwide Recall of Select Lots of Adrucil® (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) Due to Particulate Matter | Business Wire
Vu Truong - Maintenace Group Leader - Teva Parenteral Medicine Inc. | LinkedIn
Teva's 70+ manufacturing sites could be halved in efficiency drive
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Hsbc Holdings PLC Has $4.77 Million Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA) - American Banking and Market News
Teva Pharmaceuticals - Wikipedia
Teva suspects foriegn material in Adrucil injection
UPDATE 2-Teva halts output at U.S. drug plant after FDA flags concerns
Market View: Parenteral Drugs - DCAT Value Chain Insights
Teva Parenteral Medicines Initiates Voluntary Nationwide Recall of Select Lots of Adrucil® (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) Due to Particulate Matter | Business Wire
Teva Parenteral Medicines, Inc. - Form 483, 2003-08-29 - Redica Systems Store